Edwards Lifesciences Corp (EW) Risk Factors
Health CareLatest 10-K filed Feb 25, 2026Source: SEC EDGAR
WealthWire extracted and classified 32 risk factors from Edwards Lifesciences Corp’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Operations & people
8 factorsTechnology
6 factorsLegal & regulatory
6 factorsMarket & business
5 factorsHealthcare & life sciences
3 factorsESG & reputation
2 factorsFinancial
2 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that Edwards Lifesciences Corp surfaced in its latest filing.
- On September 3, 2024, we sold our Critical Care product group to Becton, Dickinson and CompanySeptember 3, 2024
- U.S. Department of Commerce investigation under Section 232 of the Trade Expansion Act of 1962 into imports of personal protective equipment, medical consumables and medical equipment
- U.S. federal government shutdown on October 1, 2025 furloughed FDA employees and stopped critical activitiesOctober 1, 2025
- The current tariff environment is dynamic, as the U.S. government has imposed, modified and paused tariffs multiple times since the beginning of 20252025
- EU MDR effective May 2017 and applicable May 2021May 2021
- A Mutual Recognition Agreement still under negotiation for the Medical Device Regulation may result in a lack of free movement of medical devices between the EU and Switzerland
Go deeper on EW
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for EW and every other S&P 500 company.